Moderna’s mRNA flu vaccine more effective than standard shot in late-stage trial

An mRNA-based flu shot could make a huge difference in flu prevention, allowing scientists to pick a better strain match.
CIDRAP

Phase 3 trial finds Moderna mRNA flu vaccine outperforms standard vaccine in older adults

The findings arrive after a swirl of regulatory uncertainty surrounding the trivalent (three-strain) vaccine, mRNA-1010.
MedPage Today on MSN

Trivalent mRNA flu shot more effective than standard vaccines

Randomized trial shows superiority in adults 50 and older ...
Chicago Tribune

It’s time to get a flu vaccination. Here’s who needs one and why.

WASHINGTON — It’s time to get a flu vaccine, and pediatricians are urging people to get them after last winter, when the U.S. saw the most flu-related child deaths in 15 years. October is the ideal ...
The Citizen

Flu season is here: Should you get the shot?

While it is recommended for most people, it is particularly important for: Yes. Influenza viruses change over time, which is ...
Now To Love

5 flu vaccine myths busted

“The flu vaccine cannot give you the flu because it contains inactivated virus or viral components only. Mild side effects ...

Australian children to test nasal spray flu vaccine that could replace the needle

A new study will explore the effects of a nasal spray flu vaccine on children’s immune systems with the end game no more ...

Moderna's mRNA flu vaccine outperforms standard shot in late-stage trial

Moderna's mRNA-based seasonal flu vaccine worked better than conventional flu shots in a late-stage international trial of ...